Mode
Text Size
Log in / Sign up

Case report describes complete remission in PDTC with combined radiotherapy and chemotherapy

Case report describes complete remission in PDTC with combined radiotherapy and chemotherapy
Photo by David Trinks / Unsplash
Key Takeaway
Consider single PDTC case report findings cautiously; treatment approaches remain controversial.

This systematic review includes a case report of a 55-year-old male with advanced poorly differentiated thyroid carcinoma (PDTC) and a literature review of the general PDTC population. For the case patient, the treatment plan combined local radiotherapy and intravenous chemotherapy. The literature review described PDTC's histological features (island-like, solid-like, or trabecular-like structures) and immunohistochemical profile, with most tumors positive for thyroid globulin and TTF-1, and some positive for p53.

The case report patient achieved complete remission, with a PET/CT scan showing no increased metabolic activity throughout the body. Overall survival for this patient is currently around one year. The literature review did not report specific treatment outcomes or comparative efficacy data for the various treatments examined.

Safety and tolerability data for the combined radiotherapy and chemotherapy regimen were not reported. Key limitations include the rarity of PDTC, with very few case reports available, and the fact that treatment methods remain controversial, requiring more clinical experience. The practice relevance is restrained; while this single case may offer insights, findings from one patient cannot be generalized, and treatment decisions should be based on broader evidence when available.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Poorly differentiated thyroid carcinoma (PDTC) is a rare and highly malignant tumor. To date, there have been very few case reports on PTCD, so its treatment methods remain controversial and require more experience. The island-like, solid-like or trabecular-like structures are manifestations of histology. Most PDTCs show positive reactions for thyroid globulin and thyroid transcription factor 1 (TTF-1) in immunohistochemical tests, and some of them also show positive reactions for p53. A 55-year-old male patient presented with a left neck mass without any obvious cause. He was diagnosed with advanced PDTC. We adopted a treatment plan combining local radiotherapy and intravenous chemotherapy. The PET/CT scan showed no increased metabolic activity throughout the body. This patient has achieved complete remission. The overall survival period is currently around one year. Additionally, we provide a comprehensive review of the disease, emphasizing incidence and definition, clinical symptoms and prognosis, molecular characteristics and treatment of PDTC, which may offer valuable insights for clinical practitioners.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.